Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
F1000Research
|
July 14, 2016
Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
Shahd Horie, John G Laffey
Frontiers in Medicine
|
November 20, 2024
Editorial: Novel targets and state of the art therapies in ARDS and sepsis
Daniel O'Toole, Shahd Horie, Emma Murphy
Intensive Care Medicine Experimental
|
December 18, 2020
Role of the adaptive immune response in sepsis
Jack Brady, Shahd Horie, John G Laffey
Current Opinion in Critical Care
|
December 5, 2020
Emerging cellular and pharmacologic therapies for acute respiratory distress syndrome
Hector Gonzalez, Shahd Horie, John G Laffey
Intensive Care Medicine
|
December 3, 2015
What's new in cell therapies in ARDS?
Shahd Horie, Gerard F Curley, John G Laffey
Current Opinion in Critical Care
|
December 10, 2015
Stem cell therapy for acute respiratory distress syndrome: a promising future?
Shahd Horie, Claire Masterson, James Devaney, et al.
Journal of Thoracic Disease
|
November 13, 2018
Cell therapy in acute respiratory distress syndrome
Shahd Horie, Hector Esteban Gonzalez, John G Laffey, et al.
Critical Care Medicine
|
November 20, 2015
Effects and Mechanisms by Which Hypercapnic Acidosis Inhibits Sepsis-Induced Canonical Nuclear Factor-κB Signaling in the Lung
Claire Masterson, Daniel O'Toole, Annemarie Leo, et al.
International Journal of Molecular Sciences
|
December 10, 2021
Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury
Shahd Horie, Hector Gonzalez, Jack Brady, et al.
Intensive Care Medicine Experimental
|
March 23, 2016
Hypercapnic acidosis attenuates pulmonary epithelial stretch-induced injury via inhibition of the canonical NF-κB pathway
Shahd Horie, Bilal Ansari, Claire Masterson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
F1000Research
|
July 14, 2016
Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
Shahd Horie, John G Laffey
Frontiers in Medicine
|
November 20, 2024
Editorial: Novel targets and state of the art therapies in ARDS and sepsis
Daniel O'Toole, Shahd Horie, Emma Murphy
Intensive Care Medicine Experimental
|
December 18, 2020
Role of the adaptive immune response in sepsis
Jack Brady, Shahd Horie, John G Laffey
Current Opinion in Critical Care
|
December 5, 2020
Emerging cellular and pharmacologic therapies for acute respiratory distress syndrome
Hector Gonzalez, Shahd Horie, John G Laffey
Intensive Care Medicine
|
December 3, 2015
What's new in cell therapies in ARDS?
Shahd Horie, Gerard F Curley, John G Laffey
Current Opinion in Critical Care
|
December 10, 2015
Stem cell therapy for acute respiratory distress syndrome: a promising future?
Shahd Horie, Claire Masterson, James Devaney, et al.
Journal of Thoracic Disease
|
November 13, 2018
Cell therapy in acute respiratory distress syndrome
Shahd Horie, Hector Esteban Gonzalez, John G Laffey, et al.
Critical Care Medicine
|
November 20, 2015
Effects and Mechanisms by Which Hypercapnic Acidosis Inhibits Sepsis-Induced Canonical Nuclear Factor-κB Signaling in the Lung
Claire Masterson, Daniel O'Toole, Annemarie Leo, et al.
International Journal of Molecular Sciences
|
December 10, 2021
Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury
Shahd Horie, Hector Gonzalez, Jack Brady, et al.
Intensive Care Medicine Experimental
|
March 23, 2016
Hypercapnic acidosis attenuates pulmonary epithelial stretch-induced injury via inhibition of the canonical NF-κB pathway
Shahd Horie, Bilal Ansari, Claire Masterson, et al.
Page
of 2